FINANCIERE DE TUBIZE (TUB.BR) Fundamental Analysis & Valuation
EBR:TUB • BE0003823409
Current stock price
222.2 EUR
-6 (-2.63%)
Last:
This TUB.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. TUB.BR Profitability Analysis
1.1 Basic Checks
- TUB had positive earnings in the past year.
- In the past year TUB has reported a negative cash flow from operations.
- TUB had positive earnings in 4 of the past 5 years.
- In the past 5 years TUB always reported negative operating cash flow.
1.2 Ratios
- With a Return On Assets value of 4.82%, TUB perfoms like the industry average, outperforming 47.06% of the companies in the same industry.
- TUB has a Return On Equity (4.94%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.82% | ||
| ROE | 4.94% | ||
| ROIC | N/A |
ROA(3y)4.63%
ROA(5y)5.57%
ROE(3y)4.88%
ROE(5y)5.78%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- TUB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. TUB.BR Health Analysis
2.1 Basic Checks
- TUB has about the same amout of shares outstanding than it did 1 year ago.
- Compared to 5 years ago, TUB has more shares outstanding
- There is no outstanding debt for TUB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- TUB has an Altman-Z score of 126.61. This indicates that TUB is financially healthy and has little risk of bankruptcy at the moment.
- With an excellent Altman-Z score value of 126.61, TUB belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
- TUB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 126.61 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- TUB has a Current Ratio of 0.03. This is a bad value and indicates that TUB is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 0.03, TUB is doing worse than 94.12% of the companies in the same industry.
- A Quick Ratio of 0.03 indicates that TUB may have some problems paying its short term obligations.
- TUB has a Quick ratio of 0.03. This is amonst the worse of the industry: TUB underperforms 94.12% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.03 | ||
| Quick Ratio | 0.03 |
3. TUB.BR Growth Analysis
3.1 Past
- The Earnings Per Share has been growing slightly by 3.47% over the past year.
- The earnings per share for TUB have been decreasing by -20.68% on average. This is quite bad
EPS 1Y (TTM)3.47%
EPS 3Y2.13%
EPS 5Y-20.68%
EPS Q2Q%17.27%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. TUB.BR Valuation Analysis
4.1 Price/Earnings Ratio
- TUB is valuated quite expensively with a Price/Earnings ratio of 106.32.
- TUB's Price/Earnings ratio is a bit more expensive when compared to the industry. TUB is more expensive than 64.71% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 27.95. TUB is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 106.32 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. TUB.BR Dividend Analysis
5.1 Amount
- With a yearly dividend of 0.33%, TUB is not a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 1.89, TUB is paying slightly less dividend.
- Compared to an average S&P500 Dividend Yield of 1.81, TUB's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.33% |
5.2 History
- On average, the dividend of TUB grows each year by 7.66%, which is quite nice.
Dividend Growth(5Y)7.66%
Div Incr Years7
Div Non Decr Years7
5.3 Sustainability
- TUB pays out 46.31% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP46.31%
EPS Next 2YN/A
EPS Next 3YN/A
TUB.BR Fundamentals: All Metrics, Ratios and Statistics
EBR:TUB (4/20/2026, 5:36:15 PM)
222.2
-6 (-2.63%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-21 2026-03-21
Earnings (Next)07-31 2026-07-31
Inst Owners7.06%
Inst Owner ChangeN/A
Ins Owners33.27%
Ins Owner ChangeN/A
Market Cap9.89B
Revenue(TTM)N/A
Net Income(TTM)93.23M
Analysts76.67
Price Target256.53 (15.45%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.33% |
Yearly Dividend1.04
Dividend Growth(5Y)7.66%
DP46.31%
Div Incr Years7
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.11%
PT rev (3m)9.11%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 106.32 | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 5.25 | ||
| P/tB | 5.25 | ||
| EV/EBITDA | N/A |
EPS(TTM)2.09
EY0.94%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0
BVpS42.36
TBVpS42.36
PEG (NY)N/A
PEG (5Y)N/A
Graham Number44.633 (-79.91%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.82% | ||
| ROE | 4.94% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)4.63%
ROA(5y)5.57%
ROE(3y)4.88%
ROE(5y)5.78%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.03 | ||
| Quick Ratio | 0.03 | ||
| Altman-Z | 126.61 |
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.47%
EPS 3Y2.13%
EPS 5Y-20.68%
EPS Q2Q%17.27%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-32.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.17%
OCF growth 3YN/A
OCF growth 5YN/A
FINANCIERE DE TUBIZE / TUB.BR Fundamental Analysis FAQ
What is the fundamental rating for TUB stock?
ChartMill assigns a fundamental rating of 2 / 10 to TUB.BR.
What is the valuation status of FINANCIERE DE TUBIZE (TUB.BR) stock?
ChartMill assigns a valuation rating of 0 / 10 to FINANCIERE DE TUBIZE (TUB.BR). This can be considered as Overvalued.
Can you provide the profitability details for FINANCIERE DE TUBIZE?
FINANCIERE DE TUBIZE (TUB.BR) has a profitability rating of 1 / 10.
What is the valuation of FINANCIERE DE TUBIZE based on its PE and PB ratios?
The Price/Earnings (PE) ratio for FINANCIERE DE TUBIZE (TUB.BR) is 106.32 and the Price/Book (PB) ratio is 5.25.
Can you provide the financial health for TUB stock?
The financial health rating of FINANCIERE DE TUBIZE (TUB.BR) is 5 / 10.